MA23179A1 - Procede de preparation d'un monohydrate cristallin d'un spirostanylglycoside - Google Patents

Procede de preparation d'un monohydrate cristallin d'un spirostanylglycoside

Info

Publication number
MA23179A1
MA23179A1 MA23485A MA23485A MA23179A1 MA 23179 A1 MA23179 A1 MA 23179A1 MA 23485 A MA23485 A MA 23485A MA 23485 A MA23485 A MA 23485A MA 23179 A1 MA23179 A1 MA 23179A1
Authority
MA
Morocco
Prior art keywords
spirostanylglycoside
preparation
crystalline monohydrate
monohydrate
crystalline
Prior art date
Application number
MA23485A
Other languages
English (en)
Inventor
B Zung Jonathan
J M Allen Douglas
A Watson Harry
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MA23179A1 publication Critical patent/MA23179A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA23485A 1993-04-28 1994-04-27 Procede de preparation d'un monohydrate cristallin d'un spirostanylglycoside MA23179A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5444993A 1993-04-28 1993-04-28

Publications (1)

Publication Number Publication Date
MA23179A1 true MA23179A1 (fr) 1994-12-31

Family

ID=21991141

Family Applications (1)

Application Number Title Priority Date Filing Date
MA23485A MA23179A1 (fr) 1993-04-28 1994-04-27 Procede de preparation d'un monohydrate cristallin d'un spirostanylglycoside

Country Status (23)

Country Link
US (1) US5760009A (fr)
EP (1) EP0696292A1 (fr)
JP (1) JPH08504830A (fr)
CN (1) CN1121722A (fr)
AP (1) AP518A (fr)
AU (1) AU6295694A (fr)
BG (1) BG100098A (fr)
BR (1) BR9406332A (fr)
CA (1) CA2161239A1 (fr)
CZ (1) CZ280195A3 (fr)
FI (1) FI941942A (fr)
HU (1) HUT67142A (fr)
IL (1) IL109374A0 (fr)
LV (1) LV11475A (fr)
MA (1) MA23179A1 (fr)
NO (1) NO954322D0 (fr)
OA (1) OA10715A (fr)
PL (1) PL311278A1 (fr)
SI (1) SI9400203A (fr)
SK (1) SK135195A3 (fr)
WO (1) WO1994025479A1 (fr)
YU (1) YU22694A (fr)
ZA (1) ZA942772B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2074006B1 (es) * 1993-07-05 1996-03-16 Pfizer Glicosidos esteroidales para tratar hipercolesterolemia.
WO1996038466A1 (fr) * 1995-05-29 1996-12-05 Pfizer Inc. Glycosides steroidiques
CN1198622C (zh) * 1998-03-26 2005-04-27 植物药物公共有限公司 用于治疗阿尔茨海默病的甾类皂苷及其衍生物
GB9923076D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
US6343258B1 (en) 1999-08-13 2002-01-29 ALEXIS Brian Method for testing for readiness for harvesting of tribulus terrestris l. having high steroidal saponin content
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
PE20011061A1 (es) 2000-02-01 2001-11-20 Procter & Gamble Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato
PE20011065A1 (es) 2000-02-01 2001-11-21 Procter & Gamble Proceso para fabricar bisfosfonatos geminales
GB0107822D0 (en) * 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
US6825960B2 (en) * 2002-01-15 2004-11-30 Inphase Technologies, Inc. System and method for bitwise readout holographic ROM
US20050130948A1 (en) * 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2926463A1 (de) * 1978-07-05 1980-01-24 Roecar Holdings Nv Spiroketaline und ihre verwendung
US4260603A (en) * 1979-01-02 1981-04-07 Pegel Karl H Sterol glycoside with activity as prostaglandin synthetase inhibitor
NZ193564A (en) * 1979-05-02 1985-01-31 Aruba Pty Ltd Steroid alkaloids from solanum sodomeum and pharmaceutical compositions
JPS56120700A (en) * 1980-02-26 1981-09-22 Wakunaga Yakuhin Kk Cardiac stimmulant
US4602003A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Synthetic compounds to inhibit intestinal absorption of cholesterol in the treatment of hypercholesterolemia
US4602005A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Tigogenin cellobioside for treating hypercholesterolemia and atherosclerosis
US5010185A (en) * 1989-06-13 1991-04-23 Pfizer Inc. Processes for tigogenin beta-cellobioside
JPH06511250A (ja) * 1991-10-04 1994-12-15 ザ、プロクター、エンド、ギャンブル、カンパニー コレステロール低下化合物及びそれらの製造方法
WO1993011150A1 (fr) * 1991-11-25 1993-06-10 Pfizer Inc. Procede de preparation de glycosides de peracyle steroides
RU94046294A (ru) * 1992-06-26 1996-10-10 Пфайзер Инк. (US) Стероидные гликозиды для лечения гиперхолестеринэмии
US5530107A (en) * 1992-10-15 1996-06-25 Pfizer Inc. Method for making steroidal peracyl glycosides
JP2767530B2 (ja) * 1993-05-06 1998-06-18 花王株式会社 物品の集荷方法及び装置

Also Published As

Publication number Publication date
CN1121722A (zh) 1996-05-01
OA10715A (en) 2002-12-09
FI941942A (fi) 1994-10-29
AU6295694A (en) 1994-11-21
HUT67142A (en) 1995-02-28
EP0696292A1 (fr) 1996-02-14
BR9406332A (pt) 1995-12-26
CZ280195A3 (en) 1996-02-14
SK135195A3 (en) 1996-03-06
US5760009A (en) 1998-06-02
FI941942A0 (fi) 1994-04-27
LV11475A (lv) 1996-08-20
WO1994025479A1 (fr) 1994-11-10
NO954322L (no) 1995-10-27
AP518A (en) 1996-08-23
HU9401209D0 (en) 1994-08-29
ZA942772B (en) 1995-10-23
BG100098A (bg) 1996-04-30
AP9400615A0 (en) 1994-01-31
YU22694A (sh) 1997-03-07
IL109374A0 (en) 1994-07-31
SI9400203A (en) 1995-06-30
PL311278A1 (en) 1996-02-05
NO954322D0 (no) 1995-10-27
CA2161239A1 (fr) 1994-11-10
JPH08504830A (ja) 1996-05-28

Similar Documents

Publication Publication Date Title
US5756817C1 (en) O-carbamoyl-phenylananinol compounds their pharmaceutically useful salts and process for preparing the same
MA23254A1 (fr) Procede de preparation de nouveaux composes
FR2689887B1 (fr) Procede de preparation d'un derive de biphenyle.
FR2707087B1 (fr) Nouveau procédé de préparation de l'ergothionéine.
MA23179A1 (fr) Procede de preparation d'un monohydrate cristallin d'un spirostanylglycoside
FR2708601B1 (fr) Procédé de cristallisation d'Iopamidol.
FR2645178B1 (fr) Procede de formation d'un film cristallin
ZA945261B (en) Process for the preparation of n-(4-hydroxyphenyl)-retinamide
FR2688506B1 (fr) Procede de preparation de sels de l'acide clavulanique.
FR2627493B1 (fr) Procede de preparation de derives d'isoquinoleine
HU9402622D0 (en) A process for the preparation of 1-substituted-5(44)-tetrazolinones
MA22401A1 (fr) Procede de preparation de sels de guinoleine
FR2635550B1 (fr) Procede de surelevation d'immeubles
FR2644161B1 (fr) Procede de preparation d'amides n-arylsubstitues
FR2644474B1 (fr) Procede de purification d'enzymes
MA23081A1 (fr) Procede de preparation de derives d'indolone
ZA923876B (en) A microbiological process for the preparation of 5-hydroxy-pyrazinoic acid
EP0474182A3 (en) Method for the purification of a bifidobacteria-proliferating substance
FR2630741B1 (fr) Procede de preparation d'acryloyloxyethoxymethyl-melamines
FR2615185B1 (fr) Procede de preparation de trifluoromethyltoluene a partir d'halomethylbenzotrifluorure
FR2610924B1 (fr) Procede de preparation d'hydroxybiphenyles
ZA911025B (en) A process for the preparation of 7-amino-3-methoxymethylceph-3-em-4-carboxylic acid
FR2615507B1 (fr) Procede de fabrication d'un compost
FR2737894B1 (fr) Procede de preparation de fluorures d'alkyletain
FR2593196B1 (fr) Procede de preparation d'un lingot cristallin de hg1-xo cdxo te